26 November 2008
Temporary Suspension of Trading on AIM
Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, notes the recent upwards movement in the Company's share price and has requested a temporary suspension of trading in its shares on AIM pending an announcement. Futura confirms that it expects to make an announcement shortly on the Competent Authority's regulatory opinion on CSD500, the Company's innovative condom.
For further information please contact:
Futura Medical plc
James Barder, Chief Executive
+44 (0) 1483 685 670
james.barder@futuramedical.com
www.futuramedical.com
Nominated Adviser:
Nomura Code Securities Limited
Phil Walker / Giles Balleny
Tel: +44 (0) 20 7776 1200
For media enquiries please contact:
Buchanan Communications Limited
Mark Court / Stasa Filiplic / George Prassas
Tel: +44 (0) 20 7466 5000